Skip to main content

Table 2 Baseline characteristics of patients included in the study

From: Doses of chloroquine in the treatment of malaria by Plasmodium vivax in patients between 2 and 14 years of age from the Brazilian Amazon basin

Characteristic2–3 (n = 22)4–8 (n = 18)9–11 (n = 19)12–14 (n = 22)
Weighta, kg12.6 (11.5–13.8)19.4 (16.4–21.8)33(31–36)46 (40–52)
Body surface areaa, m20.57 (0.54–0.60)0.79 (0.70–0.8)1.13 (1.09–1.2)1.4 (1.29–1.5)
Parasitemia at admission, geometrical mean and standard deviation4420 (3.64)3637 (2.68)1639 (3.39)3528 (5.92)
Number of patients with parasitemia on day 3,43ndnd
Parasitemia on day 3, geometrical mean and range81.44 (52–320)15 (10–32)ndnd
Parasite clearancea, h60 (24–96)48 (24–72)48 (24–60)48 (24–60)
Previous episodes of malaria, %60809090
History of fever in the least 48 h, %92859080
Time for fever clearancea, h24 (12–48)24 (12–60)24 (12–60)24 (12–60)
Hemoglobina, g/dl11.8 (10.9–12.5)12.1 (11–13.5)12.6 (11.1–12.8)13.4 (12.1–14.5)
Hematocrita, %34 (29–37)36 (29–38)36 (29–39)38 (31–40)
Plateletsa, mm3212,000 (190,000–280,000)235,000 (160,000–270,000)242,000 (185,000–310,000)260,000 (195,000–320,000)
  1. Nd not determined
  2. aValues are expressed as median and range